InsiderRadarInsider Alpha EU

TME Pharma N.V.

LEI 724500EPNADXWZ58U595

At a glance

  • Most recent filing on September 30, 2025 — a trade by van den Ouden DM on Sep 25, 2025.
  • Over the past 90 days: 0 open-market buys.
  • This page shows 24 visible filings, of which 5 open-market buys, going back to July 22, 2019.
Visible filings24
Open-market buys5
Insider score16.9out of 100, most recent scored buy
Rank of the most recent buy74

This buy came out above 74% of all scored insider buys of the past twelve months. A rank, not a forecast.

Price history and buy moments

No price series available for this security.Not matched to a price series, delisted, or outside our coverage. The reported transactions below are there all the same.

Every visible filing

What was filed, most recent first. On an award the register reports a price of 0 — nothing was paid — and then the Quantity column tells you how large the filing was.

ReportedFiled byRoleCategoryQuantityAmount
Sep 30, 2025van den Ouden DMManaging Director / Chief Executive OfficerOpen-market buy135,000€13,500
Sep 29, 2025van den Ouden DMManaging Director / Chief Executive OfficerOpen-market buy65,000€6,500
Sep 26, 2025van den Ouden DMManaging Director / Chief Executive OfficerOpen-market buy30,000€3,000
Sep 25, 2025van den Ouden DMManaging Director / Chief Executive OfficerOpen-market buy95,000€9,500
Sep 24, 2025Ouden, van denManaging Director / Chief Executive DirectorOpen-market buy300,000€27,000
Jun 30, 2025Schalop L.Supervisory DirectorAward157,115nothing paid
Jun 30, 2025Ouden, van denManaging Director / Chief Executive OfficerAward3,202,425nothing paid
Jun 30, 2025Coles S.Supervisory DirectorAward370,069nothing paid
Jun 30, 2025Petitbon M.Supervisory DirectorAward157,115nothing paid
May 23, 2025Petitbon M.Supervisory Director / ChairmanAward500,000nothing paid
May 23, 2025Schalop L.Supervisory DirectorAward200,000nothing paid
Jul 2, 2024Schalop L.Supervisory directorAward84,366nothing paid
Jul 2, 2024Coles S.Supervisory DirectorAward52,252nothing paid
Jul 2, 2024Petitbon M.Supervisory directorAward84,366nothing paid
Jul 2, 2024Izalco Management B.V.Supervisory DirectorAward111,581nothing paid
Jul 4, 2023Izalco Management B.V.Supervisory directorAward2,638nothing paid
Jul 4, 2023LifeSci Consultancy B.V. · legal entitySupervisory directorAward3,097nothing paid
Jul 4, 2023Coles S.Supervisory directorAward13,731nothing paid
Jul 4, 2022Coles S.Supervisory DirectorAward45,900nothing paid
Jul 4, 2022Izalco Management B.V.Supervisory DirectorAward272,300nothing paid
Jul 4, 2022LifeSci Consultancy B.V. · legal entitySupervisory DirectorAward45,900nothing paid
Jun 29, 2021LifeSci Consultancy B.V. · legal entitySupervisory DirectorAward134,544nothing paid
Jun 29, 2021Coles S.Supervisory DirectorAward134,544nothing paid
Jul 22, 2019deBithizy J.D.—Open-market sell2,717nothing paid

Follow this company

Loading follow status…

The insider, quant and timing scores stand apart from one another and are meant as context. There is no threshold in them (“above such and such is worth buying”), we do not add them up into a single figure, and none of it is a recommendation. How they are calculated is in the methodology.